All practice questions

4736 questions

Question 3721Question →

A 32-year-old woman is brought to the emergency department by her husband due to agitation, confusion, and shivering. She has a history of major depressive disorder, for which she is maintained on citalopram. Three days ago, she visited an urgent care clinic for a severe respiratory infection and was prescribed linezolid. On physical examination, her temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), pulse is 122/min122/\text{min}, and blood pressure is 165/98 mm Hg165/98 \text{ mm Hg}. She is diaphoretic and exhibits ocular clonus and bilateral lower extremity hyperreflexia. Intravenous fluids and benzodiazepines are administered, but her symptoms persist. The physician decides to administer cyproheptadine as a targeted antidote. Which of the following best describes the expected pharmacodynamic effect of this antidote on the dose-response curve of the involved endogenous neurotransmitter?

Show answer & explanation

Answer: Apparent increase in EC50EC_{50} with no change in EmaxE_{max}

Answer

Cyproheptadine acts as a competitive antagonist, which causes an apparent increase in the EC50EC_{50} of serotonin without changing its maximal efficacy (EmaxE_{max}).
The patient presents with classic signs of Serotonin Syndrome (hyperthermia, autonomic instability, hyperreflexia, ocular clonus) caused by the interaction between citalopram (an SSRI) and linezolid (an antibiotic with weak MAOI properties). When initial supportive care and benzodiazepines are insufficient, cyproheptadine is the antidote of choice. Cyproheptadine is a first-generation histamine antagonist with non-selective, competitive serotonin receptor antagonist properties (particularly at 5−HT2A5-HT_{2A} receptors). In pharmacodynamics, a competitive antagonist reversibly binds to the same receptor site as the endogenous agonist. This means higher concentrations of the agonist (serotonin) are required to achieve the same physiological response, leading to a shift of the dose-response curve to the right and an apparent increase in the EC50EC_{50}. However, because the binding is competitive and reversible, adding sufficiently high amounts of the agonist can overcome the antagonism, so the maximal efficacy (EmaxE_{max}) remains unchanged.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's presentation and medication history.
The patient has Serotonin Syndrome due to the combination of an SSRI (citalopram) and an antibiotic with MAOI properties (linezolid).
Recognizing the underlying toxidrome is required to determine the appropriate targeted therapy and understand its mechanism.
2
Determine the mechanism of action of the administered antidote (cyproheptadine).
Cyproheptadine is a non-selective, competitive antagonist of serotonin (particularly at 5-HT2A receptors).
The question specifically asks about the pharmacodynamic classification of this antidote.
3
Apply pharmacodynamic principles to predict the effect of a competitive antagonist on the endogenous agonist's dose-response curve.
Competitive antagonists compete for the same receptor site as the agonist, increasing the concentration of agonist needed to achieve 50% of the maximum effect (increased apparent EC50EC_{50}). However, the maximal effect (EmaxE_{max}) can still be reached if enough agonist is present.
This directly answers how the dose-response curve shifts in the presence of the antidote.

Key Concept

Competitive antagonists shift the agonist dose-response curve to the right (increase in apparent EC50EC_{50}) without altering the maximal response (EmaxE_{max}).
Estimated Time:1m 30s
Question 3722Question →

Match each patient's clinical presentation involving a discordant or potentially artifactual initial laboratory result with the most appropriate next step in laboratory evaluation.

Click a left item, then click its matching right item

Items

A 4545-year-old man with bitemporal hemianopsia and a 3.5 cm3.5\text{ cm} pituitary mass on MRI; initial serum prolactin is reported as 45 ng/mL45\text{ ng/mL} (normal: <20 ng/mL<20\text{ ng/mL}).
A 5252-year-old man with asymptomatic hyponatremia (serum sodium 121 mEq/L121\text{ mEq/L}) but a normal measured serum osmolality of 290 mOsm/kg H2O290\text{ mOsm/kg H}_2\text{O}.
A 2828-year-old pregnant woman at 1010 weeks gestation with no clinical symptoms of hyperthyroidism, found to have an elevated total T4T_4 of 15.2 μg/dL15.2\text{ }\mu\text{g/dL} (normal: 5.0−12.0 μg/dL5.0-12.0\text{ }\mu\text{g/dL}) and TSH of 1.5 μU/mL1.5\text{ }\mu\text{U/mL}.
A 3030-year-old woman applying for a job whose initial immunoassay urine drug screen is positive for amphetamines, but she solely reports taking pseudoephedrine for sinus congestion.

Matches

Show answer & explanation

Answer

The correct pairings appropriately address specific laboratory artifacts or physiologic variations: ordering serial dilutions to overcome the high-dose hook effect, checking lipids and proteins to evaluate pseudohyponatremia, measuring free T4T_4 to bypass TBG alterations in pregnancy, and using GC-MS to confirm a cross-reactive immunoassay drug screen.
Each pairing addresses a specific diagnostic challenge where the initial laboratory result is artifactual or misleading. Correctly ordering the next targeted laboratory test reveals the true physiologic or pathologic state, avoiding misdiagnosis and inappropriate treatment.

Step-by-Step Solution

1
Analyze the bitemporal hemianopsia and large pituitary mass with a paradoxically mild prolactin elevation.
Identify discordance indicative of the high-dose hook effect.
A functional macroadenoma >3 cm>3\text{ cm} typically secretes massive amounts of prolactin; paradoxical mild elevations suggest assay antibody saturation requiring serial dilutions.
2
Evaluate the patient with asymptomatic hyponatremia and normal measured osmolality.
Recognize the pattern of isotonic hyponatremia (pseudohyponatremia).
Extremely high levels of lipids or proteins displace plasma water, falsely lowering the sodium concentration when measured per total plasma volume.
3
Assess the elevated total T4T_4 in a pregnant patient with normal TSH.
Identify the hyperestrogenic state causing increased thyroxine-binding globulin (TBG).
Pregnancy increases bound T4T_4, but physiologically active free T4T_4 remains normal, necessitating specific free T4T_4 measurement to avoid misdiagnosis.
4
Evaluate the positive amphetamine screen in a patient taking pseudoephedrine.
Identify likely immunoassay cross-reactivity.
Pseudoephedrine shares structural similarities with amphetamines, requiring GC-MS for definitive quantitative confirmation.

Key Concept

Recognizing common laboratory artifacts (hook effect, pseudohyponatremia, TBG alterations, and immunoassay cross-reactivity) is essential for sequencing the correct follow-up confirmatory tests.
Estimated Time:2m 30s
Question 3723Question →

An evaluation is requested in the emergency department for a 4848-year-old female patient complaining of acute-onset abdominal discomfort. The pain localized to the right upper quadrant approximately 1212 hours prior, shortly after she consumed a heavy meal. Associated symptoms include intermittent nausea and a feeling of warmth. Vital signs demonstrate a temperature of 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), a heart rate of 96/min96\text{/min}, a respiratory rate of 18/min18\text{/min}, and a blood pressure of 132/84 mmHg132/84\text{ mmHg}. Upon physical assessment of the abdomen, the examiner places their hand firmly below the right costal margin and instructs the patient to breathe in deeply. Midway through inspiration, she suddenly gasps and stops breathing in due to a sharp spike in pain. Serum analysis shows a white blood cell count of 12,500/mm312,500\text{/mm}^3 with an unremarkable basic metabolic panel and normal lipase. Based on this characteristic examination finding, which of the following represents the optimal next diagnostic intervention?

Show answer & explanation

Answer: Perform a transabdominal ultrasonography of the right upper quadrant

Answer

Perform a transabdominal ultrasonography of the right upper quadrant
The patient's presentation of fever, right upper quadrant pain, and leukocytosis is highly suspicious for acute cholecystitis. The physical examination finding described—inspiratory arrest upon deep right subcostal palpation—is known as Murphy sign, which has a high sensitivity and specificity for gallbladder inflammation. According to current medical guidelines, the most appropriate next step in establishing this diagnosis is a transabdominal ultrasonography of the right upper quadrant. Ultrasound is preferred because it is non-invasive, avoids radiation, and is highly sensitive for detecting gallstones, gallbladder wall thickening, and pericholecystic fluid.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has postprandial right upper quadrant pain, fever, and leukocytosis, suggesting an acute inflammatory or infectious process in the hepatobiliary system.
Establishing the syndromic presentation helps narrow the differential diagnosis from general abdominal pain to specific regional etiologies.
2
Interpret the described physical examination maneuver.
The patient experiences inspiratory arrest upon deep right subcostal palpation. This is a positive Murphy sign.
Murphy sign is a highly sensitive and specific clinical finding for acute cholecystitis, as the inflamed gallbladder moves downward with the diaphragm during inspiration and contacts the examiner's hand.
3
Determine the most appropriate initial diagnostic step based on the clinical findings.
Transabdominal ultrasonography is the required next step.
Ultrasound is the most sensitive, specific, and cost-effective initial imaging modality for identifying gallstones, gallbladder wall thickening, and pericholecystic fluid without ionizing radiation.

Key Concept

A positive Murphy sign (inspiratory arrest during deep right upper quadrant palpation) is a hallmark physical examination finding of acute cholecystitis, for which right upper quadrant transabdominal ultrasound is the standard initial diagnostic step.
Estimated Time:1m 0s
Question 3724Question →

A detailed understanding of cytokine networks and immune cell interactions is essential for recognizing the pathogenesis of various inflammatory, autoimmune, and infectious conditions, as well as for utilizing targeted biologic therapies. Match each clinical presentation or pathologic process with the primary cytokine or immunologic mechanism that directly drives its development.

Click a left item, then click its matching right item

Items

Maintenance of granulomas in chronic Mycobacterium tuberculosis infection
Epidermal hyperplasia and neutrophil recruitment in psoriatic plaques
Eosinophil recruitment, activation, and survival in allergic asthma
Widespread capillary leak and distributive shock in toxic shock syndrome
Isotype switching to IgE during helminthic infections and atopic dermatitis

Matches

Show answer & explanation

Answer

The correct matching aligns specific immune mediators with their hallmark clinical manifestations: granulomas are maintained by IFN-gamma, psoriasis is driven by the IL-17/IL-23 axis, eosinophilia in asthma depends on IL-5, toxic shock syndrome is triggered by superantigen cross-linking, and IgE class switching requires IL-4.
Each pathologic process fundamentally depends on a specific immunologic pathway. Granulomatous diseases like tuberculosis rely on the Th1 response where IFN-gamma strongly activates macrophages. Psoriasis is a classic Th17-mediated disease driven by the synergistic effects of IL-17 and IL-23. Allergic asthma eosinophilia is specifically mediated by the Th2 cytokine IL-5. IgE class switching is distinctly driven by IL-4 signaling on B cells. Finally, toxic shock syndrome bypasses normal antigen processing via superantigens that broadly cross-link MHC-II and TCRs, resulting in a cytokine storm.

Step-by-Step Solution

1
Analyze the cellular infiltrate or primary pathologic feature of the described condition (e.g., granulomas require macrophage activation, allergic asthma requires eosinophils).
Identify the effector cells involved in each process.
Linking the condition to its effector cell narrows down the specific T-helper subset and corresponding cytokine.
2
Map the effector cell to its primary driving cytokine.
Macrophages map to IFN-gamma; Eosinophils map to IL-5; Neutrophils and Keratinocytes map to IL-17 and IL-23; IgE-producing B-cells map to IL-4.
Foundational immunology requires knowing the specific cytokines that activate these distinct downstream immunologic pathways.
3
Recognize the unique mechanism of massive, uncoordinated immune activation seen in toxic shock.
Identify superantigen cross-linking as the cause of the distributive shock.
This distinguishes specific antigen recognition from broad, non-specific T-cell activation which releases overwhelming amounts of TNF-alpha and IL-2.

Key Concept

Distinct immunopathologic processes are driven by specific cytokine axes (e.g., Th1/IFN-gamma for granulomas, Th2/IL-4/IL-5 for allergy, Th17/IL-17 for psoriasis, and superantigens for toxic shock), forming the foundational rationale for targeted biologic therapies.
Question 3725Question →

An ambulatory care physician is seeing a 28-year-old man who complains of severe restlessness, uncontrollable shivering, and a "racing heart" that began 24 hours ago. His past psychiatric history is notable for generalized anxiety disorder and major depressive disorder, which have been well controlled on paroxetine for the past three years. He has no other chronic medical conditions. Vital signs show a temperature of 38.4°C (101.1°F), blood pressure of 158/92 mmHg, pulse of 115/min, and respirations of 18/min. On physical examination, the patient is visibly diaphoretic and tremulous. Neurologic examination reveals prominent hyperreflexia and bilateral inducible ankle clonus. Point-of-care laboratory testing reveals a mild leukocytosis of 11,500/mm³. The physician suspects a specific toxidrome and begins a targeted medical history evaluation. Which of the following historical elements is most likely responsible for this patient's current condition?

Show answer & explanation

Answer: Initiation of an over-the-counter cough suppressant containing dextromethorphan

Answer

Initiation of an over-the-counter cough suppressant containing dextromethorphan
The correct answer involves the use of an over-the-counter cough suppressant containing dextromethorphan. This patient is presenting with classic signs of serotonin syndrome, which is characterized by the triad of autonomic instability (tachycardia, hyperthermia, diaphoresis), altered mental status (agitation, restlessness), and neuromuscular hyperactivity (tremor, prominent hyperreflexia, and clonus). Paroxetine is a selective serotonin reuptake inhibitor (SSRI). Dextromethorphan is a commonly used over-the-counter antitussive that also possesses serotonergic properties. When taken concurrently with an SSRI, it can precipitate serotonin syndrome. Thoroughly evaluating the medical history for recent over-the-counter medications is a critical step in establishing this diagnosis.

Step-by-Step Solution

1
Identify the clinical toxidrome based on vital signs and physical examination findings.
The combination of autonomic instability (fever, tachycardia, diaphoresis), altered mental status (restlessness), and neuromuscular hyperactivity (hyperreflexia, clonus) forms the classic triad of serotonin syndrome.
Recognizing the pattern of symptoms is the first step in diagnosing medication-induced toxidromes.
2
Review the patient's current medication list for potential precipitants.
The patient is taking paroxetine, a selective serotonin reuptake inhibitor (SSRI), which provides a baseline elevation in serotonergic tone.
Identifying the baseline medications helps narrow down potential drug-drug interactions that could cause the acute presentation.
3
Evaluate the missing historical elements that could interact with the patient's baseline medication to cause the identified toxidrome.
Dextromethorphan, often found in over-the-counter cough suppressants, acts as a weak serotonin reuptake inhibitor. Its addition to an SSRI is a well-known trigger for serotonin syndrome.
Targeted medical history evaluation for over-the-counter and herbal supplements is critical, as patients frequently omit them unless directly asked.

Key Concept

Eliciting a thorough history of over-the-counter medication use is essential, as agents like dextromethorphan can interact with prescribed SSRIs to precipitate life-threatening serotonin syndrome.
Estimated Time:1m 0s
Question 3726Question →

Match each of the following clinical scenarios with the most accurate corresponding pharmacokinetic alteration expected in that patient.

Click a left item, then click its matching right item

Items

A patient with acute decompensated heart failure who is administered an intravenous drug with a high hepatic extraction ratio
A patient with oliguric end-stage renal disease who is prescribed a renally cleared hydrophilic antibiotic
A patient with severe hypoalbuminemia secondary to nephrotic syndrome who is taking a highly protein-bound drug
A patient taking an oral contraceptive pill who is initiated on rifampin therapy for a latent tuberculosis infection

Matches

Show answer & explanation

Answer

The correct matches are: 1) Heart failure matches with decreased systemic clearance due to reduced organ perfusion. 2) End-stage renal disease matches with unchanged loading dose but decreased maintenance dose. 3) Hypoalbuminemia matches with increased apparent volume of distribution and decreased total steady-state concentration. 4) Rifampin therapy matches with decreased elimination half-life and decreased steady-state plasma concentration.
Each clinical scenario alters specific pharmacokinetic parameters. Heart failure reduces hepatic blood flow, impairing clearance of flow-dependent (high-extraction) drugs. Renal failure necessitates reduced maintenance doses due to lower clearance, but loading doses remain unchanged because the volume of distribution is stable. Hypoalbuminemia increases the free fraction of protein-bound drugs, raising the volume of distribution and lowering total steady-state levels due to increased clearance of total drug. Enzyme inducers like rifampin increase clearance, thereby shortening the half-life and lowering steady-state concentrations of substrate drugs.

Step-by-Step Solution

1
Identify the primary pharmacokinetic parameter affected by heart failure for high-extraction ratio drugs.
Hepatic blood flow is reduced, which is the primary determinant of clearance for high-extraction ratio drugs.
Clearance of high-extraction ratio drugs is directly proportional to hepatic blood flow.
2
Determine the effect of renal failure on loading versus maintenance doses.
The maintenance dose must be decreased, but the loading dose is unchanged.
The maintenance dose depends on clearance (which is reduced in renal failure), while the loading dose depends on the volume of distribution (which is mostly unaffected by renal failure for hydrophilic drugs).
3
Analyze the effect of low albumin on highly protein-bound drugs.
The fraction of unbound drug increases, leading to an increased volume of distribution and decreased total plasma concentration.
Unbound drug equilibrates into extravascular compartments and is more readily available for hepatic metabolism.
4
Assess the impact of CYP450 induction by rifampin on co-administered drugs.
Metabolism is accelerated, leading to decreased half-life and lower steady-state concentration.
Enzyme induction increases hepatic clearance, which is inversely proportional to half-life and steady-state concentration.

Key Concept

Various disease states and drug interactions predictably alter specific pharmacokinetic parameters such as clearance, volume of distribution, half-life, and required dosing regimens.
Question 3727Question →

Obtaining a thorough dietary and non-prescription supplement history is a critical component of medical evaluation, as patients often omit these exposures unless specifically asked. Match each unique patient history profile to the clinical presentation most commonly associated with that hidden exposure.

Click a left item, then click its matching right item

Items

An edentulous patient who applies excessive amounts of over-the-counter denture fixative paste multiple times daily.
A patient with stage 4 chronic kidney disease who recently consumed large volumes of homemade carambola (star fruit) juice.
A health-conscious individual who consumes several handfuls of raw Brazil nuts every day as part of a micronutrient-dense diet.
A bodybuilder utilizing a pre-workout dietary supplement heavily fortified with Citrus aurantium (bitter orange) extract.

Matches

Show answer & explanation

Answer

Denture paste overuse matches to copper deficiency myeloneuropathy; star fruit consumption in CKD matches to intractable hiccups and neurotoxicity; excess Brazil nut intake matches to selenosis (alopecia/garlic breath); and bitter orange extract matches to sympathomimetic cardiovascular toxicity.
Each specific dietary or supplement history directly precipitates a well-described toxicological syndrome. Zinc in denture paste causes secondary copper deficiency; caramboxin in star fruit causes neurotoxicity in the setting of renal failure; excessive selenium in Brazil nuts causes selenosis; and synephrine in bitter orange acts as a dangerous sympathomimetic.

Step-by-Step Solution

1
Evaluate the history of excessive denture fixative use.
Identifies a source of excessive exogenous zinc ingestion.
High zinc intake upregulates intestinal metallothionein, which selectively binds and traps dietary copper, leading to systemic copper deficiency presenting as myeloneuropathy and anemia.
2
Analyze the consumption of star fruit in the context of chronic kidney disease.
Recognizes caramboxin toxicity.
Caramboxin is a potent neurotoxin normally cleared by the kidneys; in severe renal impairment, it accumulates and classically causes intractable hiccups followed by confusion and seizures.
3
Assess the daily intake of large quantities of Brazil nuts.
Identifies a high risk for selenosis.
Brazil nuts contain extremely high levels of selenium. Chronic overconsumption leads to toxicity presenting with alopecia, nail brittleness, and a characteristic garlic breath odor.
4
Review the components of the pre-workout supplement, specifically bitter orange.
Identifies synephrine exposure.
Citrus aurantium (bitter orange) contains synephrine, an ephedrine-like alkaloid that induces profound sympathomimetic effects, including hypertension and potential myocardial ischemia.

Key Concept

Identifying specific hidden dietary and supplement exposures during medical history evaluation that lead to unique toxicological syndromes.
Question 3728Question →

A 26-year-old woman is evaluated in the hematology clinic prior to a scheduled elective cholecystectomy due to an incidentally discovered prolonged activated partial thromboplastin time (aPTT) on routine preoperative laboratory screening. She reports a history of heavy menstrual bleeding necessitating the use of oral contraceptives. She also states she experienced prolonged bleeding following a wisdom tooth extraction 5 years ago. She has no history of deep venous thrombosis, joint swelling, or spontaneous bruising. Her family history is unremarkable for known bleeding disorders. Physical examination is within normal limits with no petechiae or ecchymoses.

Laboratory results:
Prothrombin time (PT): 11 seconds (Normal: 11-15 sec)
Activated partial thromboplastin time (aPTT): 48 seconds (Normal: 25-35 sec)
Platelet count: 280,000/μL280,000/\mu L

A 1:11:1 mixing study with normal pooled plasma is performed. The patient's aPTT corrects to 29 seconds immediately, and remains 30 seconds after a 2-hour incubation.

Which of the following is the most appropriate next step in laboratory evaluation?

Show answer & explanation

Answer: von Willebrand factor antigen, ristocetin cofactor activity, and Factor VIII coagulant activity

Answer

The most appropriate next step is to order von Willebrand factor antigen, ristocetin cofactor activity, and Factor VIII coagulant activity.
The correct answer identifies the diagnostic panel for von Willebrand disease (vWD). The patient's clinical presentation (menorrhagia, prolonged bleeding after tooth extraction) is characteristic of a defect in primary hemostasis. Her laboratory evaluation shows an isolated prolonged aPTT with a normal platelet count. The 1:1 mixing study corrects immediately and remains corrected after a 2-hour incubation, confirming a coagulation factor deficiency rather than an inhibitor (which would either fail to correct immediately, or correct initially but prolong after incubation, as seen with Factor VIII autoantibodies). The combination of mucosal bleeding, an isolated prolonged aPTT, and full correction on a mixing study is highly suggestive of vWD. Von Willebrand factor is necessary for platelet adhesion and serves as a carrier protein for Factor VIII, protecting it from rapid degradation. A deficiency in vWF leads to a concomitant Factor VIII deficiency, prolonging the aPTT. Therefore, the most appropriate diagnostic next step is a comprehensive vWD panel.

Step-by-Step Solution

1
Analyze the bleeding history.
The patient has a history of heavy menses and dental bleeding, indicating a primary hemostatic defect (mucosal bleeding).
This helps differentiate between platelet/vWF disorders and coagulation factor deficiencies, which typically cause deep tissue or joint bleeding.
2
Evaluate the baseline coagulation profile.
PT is normal, but aPTT is isolated and prolonged.
An isolated prolonged aPTT points to an abnormality in the intrinsic coagulation pathway (Factors VIII, IX, XI, XII) or von Willebrand disease.
3
Interpret the mixing study results.
The immediate correction and sustained correction at 2 hours confirm a factor deficiency, ruling out both immediate and time-dependent inhibitors.
Immediate inhibitors (like lupus anticoagulant) fail to correct immediately. Time-dependent inhibitors (like acquired FVIII autoantibodies) correct immediately but prolong after incubation.
4
Synthesize clinical and laboratory findings to determine the most likely diagnosis.
A young woman with mucosal bleeding and a confirmed factor deficiency (likely Factor VIII secondary to low vWF) should be tested for von Willebrand disease.
vWD perfectly explains both the clinical phenotype of primary hemostatic bleeding and the prolonged aPTT, making a comprehensive vWD panel the most appropriate targeted workup.

Key Concept

Evaluation of an isolated prolonged aPTT using a mixing study with 2-hour incubation to distinguish factor deficiencies from time-dependent inhibitors, and sequencing diagnostic testing based on clinical presentation.
Estimated Time:1m 30s
Question 3729Question →

During comprehensive neurological physical examinations, observing a patient's gait provides critical diagnostic clues regarding the precise location of neurological lesions. Match each detailed physical examination description of a gait abnormality with its most likely underlying neuroanatomical localization or pathophysiological mechanism.

Click a left item, then click its matching right item

Items

Difficulty initiating walking with feet appearing stuck to the floor, followed by a short-stepped, broad-based shuffling gait.
Excessive hip and knee flexion during the swing phase of walking, resulting in the foot slapping heavily against the floor.
Stooped posture with progressively accelerating, rapid, short steps and reduced arm swing.
Wide-based, unsteady gait with heavy heel strikes, which markedly deteriorates when the patient is deprived of visual input.
Stiff, slow gait with circumduction of the legs and a tendency for the knees to cross the midline during movement.

Matches

Show answer & explanation

Answer

The accurate clinical match pairs apraxic gait to frontal lobe dysfunction, steppage gait to peroneal nerve or L5 root lesions, festinating gait to substantia nigra degeneration, sensory ataxia to dorsal column disruption, and spastic diplegia to bilateral corticospinal tract lesions.
Gait analysis is a high-yield component of the neurological physical examination, serving as a powerful localizing tool. 1) An apraxic (magnetic) gait involves a broad base and feet that seem glued to the floor, commonly caused by normal pressure hydrocephalus affecting descending frontal lobe tracts. 2) A steppage gait features excessive leg lifting to prevent toes from dragging, indicating a lower motor neuron lesion of the deep fibular nerve or L5 radiculopathy. 3) A festinating gait features stooped posture and rapid, accelerating steps, classic for the substantia nigra dopaminergic depletion seen in Parkinson disease. 4) A sensory ataxic gait involves heavy heel strikes and worsens notably without visual input (positive Romberg), localizing to the dorsal columns or large myelinated peripheral nerves. 5) A spastic diplegic (scissors) gait presents with leg stiffness and circumduction from increased adductor tone, indicating bilateral upper motor neuron (corticospinal tract) damage.

Step-by-Step Solution

1
Analyze the first clinical description noting 'feet stuck to the floor' and broad-based shuffling.
Identify this as an apraxic (magnetic) gait.
This finding points to higher-level motor dysfunction, directly localizing to frontal lobe impairment.
2
Evaluate the second description highlighting 'excessive hip/knee flexion' and 'foot slapping'.
Identify this as a steppage gait secondary to foot drop.
Foot drop results from an inability to dorsiflex the ankle, requiring compensation and localizing to the deep fibular nerve or L5 root.
3
Examine the third description featuring a stooped posture with accelerating, rapid steps (festination).
Map this directly to parkinsonian syndromes.
These syndromes are fundamentally driven by a loss of dopaminergic neurons in the substantia nigra.
4
Assess the fourth description noting heavy heel strikes and marked deterioration without visual input.
Identify this as a sensory ataxic gait (exhibiting a positive Romberg sign).
This indicates a critical loss of proprioception, localizing to the dorsal columns or large peripheral sensory nerves.
5
Review the final description of a stiff gait with legs crossing the midline (scissoring).
Identify this as a spastic diplegic gait.
Scissoring is secondary to bilateral leg adductor spasticity, which strictly implies bilateral corticospinal tract (upper motor neuron) damage.

Key Concept

Neuroanatomical localization of gait abnormalities through physical examination findings
Question 3730Question →

Match the following arterial blood gas (ABG) profiles on room air to their most appropriate primary acid-base disorder.

Click a left item, then click its matching right item

Items

pH=7.22\text{pH} = 7.22, pCO2=65 mmHg\text{pCO}_2 = 65 \text{ mmHg}, HCO3−=26 mEq/L\text{HCO}_3^- = 26 \text{ mEq/L}
pH=7.54\text{pH} = 7.54, pCO2=25 mmHg\text{pCO}_2 = 25 \text{ mmHg}, HCO3−=22 mEq/L\text{HCO}_3^- = 22 \text{ mEq/L}
pH=7.25\text{pH} = 7.25, pCO2=30 mmHg\text{pCO}_2 = 30 \text{ mmHg}, HCO3−=12 mEq/L\text{HCO}_3^- = 12 \text{ mEq/L}
pH=7.48\text{pH} = 7.48, pCO2=42 mmHg\text{pCO}_2 = 42 \text{ mmHg}, HCO3−=32 mEq/L\text{HCO}_3^- = 32 \text{ mEq/L}

Matches

Show answer & explanation

Answer

Each ABG profile matches a specific acid-base disorder determined by analyzing the directional deviation of pH combined with the primary altering variable (pCO2 for respiratory, HCO3 for metabolic).
Correctly identifying simple acid-base disorders requires a two-step approach: first, defining the primary disorder based on pH (acidosis vs. alkalosis), and second, identifying the driving variable (pCO2 for respiratory vs. bicarbonate for metabolic).

Step-by-Step Solution

1
Examine the pH to determine the primary state of the blood.
A pH below 7.35 indicates primary acidemia, while a pH above 7.45 indicates primary alkalemia.
The physiological compensatory mechanisms never fully overcorrect the pH, meaning the pH value always points reliably toward the primary underlying disorder.
2
Evaluate the pCO2 and HCO3 to see which value aligns with the pH shift.
Identifies whether the root cause is respiratory or metabolic.
If the pH and pCO2 move in opposite directions, the disorder is respiratory. If the pH and HCO3 move in the same direction, the disorder is metabolic.

Key Concept

Basic acid-base disorders can be successfully identified by confirming the direction of the pH derangement and matching it to the primary abnormality in either pCO2 or bicarbonate.
Question 3731Question →

A 52-year-old woman presents to the clinic complaining of severe fatigue, generalized joint aches, and a new rash on her lower extremities that appeared 33 days ago. She has a history of intravenous drug use in her twenties but states she has been abstinent for over two decades. On physical examination, her temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 145/90 mm Hg145/90 \text{ mm Hg}, and pulse is 82/min82/\text{min}. Examination of the legs reveals non-blanching, erythematous macules and papules that coalesce into plaques. Laboratory studies reveal the following:

Laboratory ParameterValue
Hemoglobin11.2 g/dL11.2 \text{ g/dL}
Platelets180,000/mm3180,000/\text{mm}^3
Serum creatinine1.6 mg/dL1.6 \text{ mg/dL}
Aspartate aminotransferase (AST)85 U/L85 \text{ U/L}
Alanine aminotransferase (ALT)102 U/L102 \text{ U/L}
Hepatitis C virus RNA1,500,000 IU/mL1,500,000 \text{ IU/mL}
Complement C395 mg/dL95 \text{ mg/dL} (Normal: 80−16080-160)
Complement C44 mg/dL4 \text{ mg/dL} (Normal: 15−4515-45)
Rheumatoid factorPositive

Urinalysis shows 2+2+ protein, 15−2015-20 red blood cells/hpf, and occasional red blood cell casts. Which of the following best describes the fundamental immunopathologic mechanism responsible for this patient's cutaneous and renal findings?

Show answer & explanation

Answer: Vascular deposition of immune complexes containing monoclonal IgM directed against the Fc portion of IgG

Answer

Vascular deposition of immune complexes containing monoclonal IgM directed against the Fc portion of IgG
The correct answer identifies the underlying pathophysiology of Type II mixed cryoglobulinemia. In patients with chronic Hepatitis C, continuous immune stimulation can lead to the production of monoclonal IgM antibodies that possess Rheumatoid Factor activity. Rheumatoid Factor is defined as an autoantibody (usually IgM) directed against the Fc portion of human IgG. These IgM-IgG-HCV immune complexes precipitate in cold temperatures (cryoglobulins) and deposit in the vascular endothelium of the skin, joints, and kidneys. This Type III hypersensitivity reaction intensely activates the classical complement pathway, leading to significant consumption of C4 (which is often profoundly low) while C3 may remain normal or mildly decreased.

Step-by-Step Solution

1
Synthesize the clinical presentation.
The patient has palpable purpura, arthralgias, and glomerulonephritis (RBC casts, elevated creatinine) in the setting of untreated chronic Hepatitis C infection.
Identifying the clinical triad and the underlying infectious trigger focuses the differential diagnosis on extrahepatic manifestations of HCV.
2
Analyze the immunologic laboratory profile.
The laboratory profile shows a markedly low C4 with a normal C3, alongside a positive Rheumatoid Factor.
Classical complement pathway activation strongly consumes C4. A positive Rheumatoid Factor in a patient without Rheumatoid Arthritis, combined with isolated low C4 and HCV, points directly to mixed cryoglobulinemia.
3
Determine the molecular mechanism of the identified disease.
Type II mixed cryoglobulinemia is characterized by the formation of immune complexes composed of polyclonal IgG and a monoclonal IgM antibody that acts as a Rheumatoid Factor (targeting the Fc portion of the IgG).
Understanding the exact composition of the cryoglobulins is required to select the correct immunopathologic mechanism.

Key Concept

Type II mixed cryoglobulinemia is a Type III hypersensitivity reaction strongly associated with Hepatitis C, characterized by immune complexes of polyclonal IgG and monoclonal IgM (Rheumatoid Factor) that activate the classical complement pathway, leading to low C4 levels, palpable purpura, and glomerulonephritis.
Estimated Time:2m 0s
Question 3732Question →

A 34-year-old woman presents to the clinic with a 2-month history of unintentional weight loss, frequent palpitations, and heat intolerance. On physical examination, her heart rate is 112/min112/\text{min}, and she has a fine resting tremor. Neck examination reveals a diffusely enlarged, non-tender thyroid gland. Laboratory evaluation demonstrates a thyroid-stimulating hormone (TSH) level of 0.01 μU/mL0.01 \text{ }\mu\text{U/mL} (reference: 0.4−4.0 μU/mL0.4-4.0 \text{ }\mu\text{U/mL}) and a free thyroxine (T4T_4) level of 3.2 ng/dL3.2 \text{ ng/dL} (reference: 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL}). She is diagnosed with Graves disease and prescribed methimazole. To understand the cellular mechanism of this patient's disease and her new medication, the physician reviews the physiological sequence of thyroid hormone synthesis. Arrange the following steps of normal thyroid hormone synthesis and release in the correct chronological order, beginning with the initial uptake of the raw material from the bloodstream.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Basolateral iodide transport (NIS) -> Apical iodide transport (Pendrin) -> Oxidation (TPO) -> Organification -> Coupling -> Endocytosis/Proteolysis.
Thyroid hormone synthesis begins with the active concentration of inorganic iodide from the blood into the follicular cell via the basolateral sodium-iodide symporter (NIS). Iodide then diffuses across the cell and is transported into the follicular lumen (colloid) via pendrin on the apical membrane. At the apical-colloid interface, thyroid peroxidase (TPO) oxidizes iodide to a reactive iodine species. This iodine is immediately organified onto tyrosine residues of the large thyroglobulin protein, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). TPO then catalyzes the coupling of these molecules to form T3T_3 and T4T_4, which remain attached to thyroglobulin in the colloid. Upon stimulation (e.g., by TSH or TSH-receptor antibodies in Graves disease), the cell endocytoses the colloid. Lysosomes fuse with these vesicles and proteolytically cleave the thyroglobulin, releasing free T3T_3 and T4T_4 into the bloodstream.

Step-by-Step Solution

1
Identify the starting point of the pathway.
Basolateral transport of iodide.
Iodide must first be extracted from the capillary blood into the thyroid follicular cell via the Na+/I−\text{Na}^+/\text{I}^- symporter (NIS) on the basolateral membrane.
2
Determine the next compartment the substrate must reach.
Apical transport into the colloid.
Hormone synthesis occurs in the follicular lumen. Iodide exits the apical membrane via the pendrin transporter.
3
Sequence the three enzymatic steps catalyzed by Thyroid Peroxidase (TPO).
Oxidation, then organification, then coupling.
Iodide is oxidized to iodine, which is then organified onto thyroglobulin tyrosine residues (forming MIT/DIT). Finally, MIT and DIT are coupled to form T3T_3 and T4T_4 on the thyroglobulin backbone.
4
Identify the final step for hormone release.
Endocytosis and lysosomal proteolysis.
The colloid containing iodinated thyroglobulin is endocytosed back into the follicular cell, where lysosomes cleave the active T3T_3 and T4T_4 for basolateral secretion.

Key Concept

Thyroid hormone synthesis requires a highly coordinated sequence of membrane transport (NIS, pendrin) and enzymatic reactions catalyzed by thyroid peroxidase (oxidation, organification, coupling) occurring at the apical membrane and within the colloid space.
Question 3733Question →

An independent 62-year-old gentleman is brought to the emergency department by his daughter due to an abrupt onset of a severe room-spinning sensation that began 6 hours ago. He reports intense nausea and an inability to walk without assistance. His past medical history is significant for essential hypertension and hyperlipidemia. Vital signs show a blood pressure of 165/95 mmHg, heart rate of 88/min, and respiratory rate of 16/min. The patient is alert and fully oriented. Cardiopulmonary examination is unremarkable. During the neurological evaluation, the physician performs a provocative positioning test by rapidly moving the patient from a sitting to a supine position with his head turned 45 degrees. This maneuver immediately elicits purely vertical, down-beating nystagmus that persists continuously for over 2 minutes without diminishing in intensity. The patient's hearing is intact bilaterally to finger rub. Based on these physical examination findings, which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
The correct action is to obtain magnetic resonance imaging (MRI) of the brain. The physician performed the Dix-Hallpike maneuver, a provocative physical examination test. The patient exhibited purely vertical, down-beating nystagmus that occurred immediately (no latency period) and persisted without fatiguing. These physical examination findings are highly specific for a central nervous system etiology, such as a cerebellar or brainstem infarction. In a patient with vascular risk factors presenting with acute central vertigo, neuroimaging is paramount. MRI of the brain is the most appropriate next step because it is significantly more sensitive than computed tomography (CT) for detecting acute ischemia in the posterior fossa.

Step-by-Step Solution

1
Analyze the patient's presentation and provocative physical examination findings.
The patient has acute vertigo with purely vertical, non-fatiguing nystagmus that lacks a latency period during a positioning maneuver.
Accurate interpretation of nystagmus characteristics is required to distinguish between peripheral and central causes of vertigo.
2
Correlate the physical examination findings with the underlying pathophysiology.
These specific nystagmus characteristics strongly indicate a central nervous system lesion, such as a posterior circulation stroke.
Purely vertical nystagmus is a red flag for central pathology, whereas peripheral nystagmus is typically mixed horizontal-torsional, fatigable, and has a latency period before onset.
3
Determine the most appropriate next step in management based on the diagnostic deduction.
Urgent neuroimaging with an MRI of the brain is required.
MRI is the most sensitive imaging modality for evaluating ischemic strokes in the posterior fossa (brainstem and cerebellum).

Key Concept

Differentiating central from peripheral vertigo based on physical examination findings (nystagmus characteristics).
Estimated Time:1m 30s
Question 3734Question →

A 66-year-old woman is evaluated in the emergency department for a 4-day history of severe, non-bloody diarrhea. She reports having up to 10 watery bowel movements daily, accompanied by diffuse abdominal cramping and a low-grade fever. She has a history of metastatic melanoma and began therapy with pembrolizumab 6 weeks ago. Her temperature is 37.8°C (100.0°F), blood pressure is 110/70 mm Hg, and pulse is 108/min. Physical examination reveals a diffusely tender abdomen with hyperactive bowel sounds, but no rebound tenderness or guarding. Laboratory studies show a serum potassium of 3.1 mEq/L and an elevated C-reactive protein. Stool PCR for *Clostridioides difficile* and routine enteric stool cultures are negative. A flexible sigmoidoscopy reveals diffuse mucosal erythema, loss of vascular pattern, and patchy ulcerations. Biopsy demonstrates a dense lymphoplasmacytic infiltrate expanding the lamina propria. In addition to intravenous fluid resuscitation, which of the following is the most appropriate targeted intervention and its corresponding immunopathologic rationale?

Show answer & explanation

Answer: Intravenous methylprednisolone; to suppress unrestricted T-cell activation resulting from the blockade of negative costimulatory signals

Answer

Intravenous methylprednisolone; to suppress unrestricted T-cell activation resulting from the blockade of negative costimulatory signals.
Pembrolizumab is an IgG4 monoclonal antibody that targets Programmed Cell Death Protein 1 (PD-1). Normally, the interaction between PD-1 on T cells and PD-L1/PD-L2 on target cells provides a critical negative costimulatory signal that maintains peripheral tolerance and prevents autoimmunity. By blocking this interaction, pembrolizumab enhances the anti-tumor immune response but simultaneously removes the "brakes" on the immune system, leading to unrestrained T-cell activation. This uninhibited cell-mediated immunity can attack healthy host tissues, resulting in immune-related adverse events (irAEs). This patient has severe (Grade 3) immune-related colitis. The standard of care for severe irAEs requires immediately holding the immunotherapy and initiating high-dose systemic corticosteroids, such as intravenous methylprednisolone, to aggressively suppress the hyperactive T-cell response and prevent colonic perforation.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's history and presentation.
The patient presents with severe (Grade 3) colitis (10 daily stools, cramping) shortly after initiating pembrolizumab, an immune checkpoint inhibitor.
Recognizing the temporal association between immunotherapy and inflammatory symptoms is critical for establishing a differential diagnosis.
2
Eliminate alternative infectious or cytotoxic etiologies.
Negative highly-sensitive stool PCR effectively rules out C. difficile. The drug class (immunotherapy) rules out direct cytotoxic enteropathy.
Ruling out infection is mandatory before initiating high-dose immunosuppression in any patient with severe colitis.
3
Determine the specific immunopathogenesis of the drug.
Pembrolizumab blocks PD-1, preventing the delivery of negative costimulatory signals to T cells, leading to a break in peripheral tolerance and unregulated tissue damage.
Understanding the mechanism of action explains the biopsy findings (lymphoplasmacytic infiltrate) and guides targeted reversal.
4
Select the appropriate pharmacologic management based on severity.
Grade 3 immune-related adverse events (irAEs) require immediate suspension of the offending agent and administration of high-dose systemic corticosteroids (e.g., IV methylprednisolone).
Prompt immunosuppression halts the cell-mediated destruction of the colon, preventing severe complications like toxic megacolon or perforation.

Key Concept

Immune checkpoint inhibitor-mediated colitis pathogenesis and step-wise management.
Question 3735Question →

During morning rounds on the medical ward, a physician evaluates a 62-year-old man who was admitted overnight with a 3-day history of profound generalized muscle weakness, severe myalgias, and dark brown urine. The patient has a background of ischemic heart disease, hypertension, and mixed dyslipidemia, which are managed chronically with daily aspirin, metoprolol, ramipril, and simvastatin. Upon reviewing the electronic health record, the physician notes that 10 days prior, the patient visited an out-of-state urgent care clinic for a high fever and productive cough. He was diagnosed with community-acquired pneumonia and completed a 7-day course of an oral antimicrobial agent. Current laboratory studies reveal a serum creatinine of 2.62.6 mg/dL (baseline 1.11.1 mg/dL) and a creatine kinase level of 14,50014,500 U/L. Which of the following antimicrobial agents, if identified during a reconciliation of the patient's recent medical history, most likely precipitated his current clinical condition?

Show answer & explanation

Answer: Clarithromycin

Answer

Clarithromycin
The correct answer is clarithromycin because it is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme. Simvastatin is heavily dependent on CYP3A4 for hepatic clearance. When these two medications are taken concurrently, simvastatin metabolism is blocked, leading to toxic serum concentrations. This accumulation causes severe statin-induced myopathy, progressing to frank rhabdomyolysis (evidenced by the markedly elevated creatine kinase). The subsequent release of myoglobin into the bloodstream causes pigment-induced acute kidney injury (evidenced by the elevated creatinine and dark urine). A comprehensive medical history evaluation requires reconciling recent acute prescriptions with chronic maintenance medications to identify such dangerous pharmacokinetic interactions.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and acute laboratory findings.
The patient exhibits severe muscle weakness, dark urine, grossly elevated creatine kinase (14,500 U/L), and acute kidney injury (creatinine 2.6 mg/dL).
This constellation of findings confirms a diagnosis of acute rhabdomyolysis with secondary pigment-induced acute kidney injury.
2
Review the patient's chronic medication list for potential precipitants of this condition.
The patient is chronically taking simvastatin, an HMG-CoA reductase inhibitor.
Statins carry a known, dose-dependent risk of myopathy and rhabdomyolysis, particularly when their hepatic clearance is impaired.
3
Evaluate the recent medical history for new variables that alter the pharmacokinetics of the chronic medications.
The patient recently completed a course of antibiotics for community-acquired pneumonia. Simvastatin is primarily metabolized by the hepatic cytochrome P450 3A4 (CYP3A4) enzyme.
Connecting the recent acute illness treatment to the chronic medication profile is the core of thorough medical history evaluation.
4
Determine which of the potential antibiotic treatments is a potent CYP3A4 inhibitor.
Clarithromycin is a macrolide antibiotic that strongly inhibits CYP3A4, whereas the other options do not.
Identifying the specific drug-drug interaction explains the sudden toxic accumulation of simvastatin and the resulting clinical disaster.

Key Concept

Patients on CYP3A4-metabolized statins (like simvastatin) are at high risk for severe rhabdomyolysis if prescribed a potent CYP3A4 inhibitor (like clarithromycin).
Question 3736Question →

A hematology-oncology tumor board is reviewing molecular pathology reports for several adult patients with newly diagnosed leukemias and lymphomas. The board discusses how these specific chromosomal abnormalities dictate both the fundamental pathophysiology and the selection of targeted therapies. Match each identified cytogenetic translocation with its corresponding primary molecular consequence.

Click a left item, then click its matching right item

Items

t(9;22) (q34;q11)
t(15;17) (q24;q21)
t(14;18) (q32;q21)
t(11;14) (q13;q32)

Matches

Show answer & explanation

Answer

The correct pairings match t(9;22) with constitutive tyrosine kinase activation, t(15;17) with halting of myeloid maturation, t(14;18) with overexpression of an anti-apoptotic protein, and t(11;14) with promoting the G1 to S phase transition.
Each chromosomal translocation involves the juxtaposition of specific genes that uniquely alter cellular function. t(9;22) creates a BCR-ABL fusion tyrosine kinase. t(15;17) creates PML-RARA which suppresses retinoic acid-induced transcription, halting differentiation. t(14;18) translocates BCL-2 to the highly active IgH promoter, preventing apoptosis. t(11;14) translocates Cyclin D1 to the IgH promoter, promoting cell cycle progression.

Step-by-Step Solution

1
Analyze each cytogenetic abnormality to identify the associated hematologic malignancy.
t(9;22) is CML; t(15;17) is APL; t(14;18) is Follicular Lymphoma; t(11;14) is Mantle Cell Lymphoma.
Identifying the clinical syndrome is the necessary first step to deducing the underlying molecular mechanism.
2
Determine the molecular consequence driven by the specific gene fusion or promoter swapping for each malignancy.
CML involves BCR-ABL (tyrosine kinase); APL involves PML-RARA (differentiation block); Follicular Lymphoma involves BCL-2 (anti-apoptotic); Mantle Cell Lymphoma involves Cyclin D1 (cell cycle progression).
Understanding the precise mechanistic impact of the mutation is essential for correlating the pathology with targeted therapies (e.g., imatinib for CML, ATRA for APL).

Key Concept

Molecular basis of hematologic malignancies driven by specific chromosomal translocations.
Estimated Time:1m 30s
Question 3737Question →

A 68-year-old woman is admitted to the hospital with a complicated intra-abdominal infection. She is started on a newly approved intravenous antimicrobial agent. The standard maintenance dose of this medication for patients with normal renal function (defined as a creatinine clearance of 100 mL/min100 \text{ mL/min}) is 600 mg600 \text{ mg} administered every 24 hours. Pharmacokinetic data indicate that in healthy individuals, 60%60\% of the drug is eliminated unchanged in the urine, while the remaining 40%40\% undergoes hepatic metabolism. The patient's basic metabolic panel reveals an elevated serum creatinine, and her creatinine clearance is estimated to be 25 mL/min25 \text{ mL/min}. Assuming linear pharmacokinetics and normal hepatic function, what should be the new daily maintenance dose in mg\text{mg} to achieve the same steady-state average drug concentration as a patient with normal renal function?

Show answer & explanation

Answer: 330

Answer

330
In drugs with mixed elimination, only the fraction of the drug eliminated by the affected organ should be adjusted. The patient has 25% of normal renal function (25/100). The original dose relies on 60% renal clearance and 40% hepatic clearance. The new renal clearance fraction is 60% * 25% = 15%. Adding the unchanged hepatic clearance (40%), the patient's total functional clearance is 55% of normal. Multiplying the standard dose of 600 mg by 0.55 gives 330 mg.

Step-by-Step Solution

1
Determine normal elimination fractions
Hepatic fraction (fmf_m) = 0.40, Renal fraction (fef_e) = 0.60
To properly adjust dosing for organ dysfunction, the contribution of each elimination pathway must be quantified.
2
Calculate the ratio of the patient's renal function to normal renal function
Ratio = 25 / 100 = 0.25
This ratio determines how much of the normal renal clearance capacity is currently functioning.
3
Calculate the patient's adjusted total clearance factor
Total clearance factor = 0.40 (hepatic) + (0.60 * 0.25) (renal) = 0.40 + 0.15 = 0.55
The new total clearance is the sum of the unaffected hepatic clearance and the diminished renal clearance.
4
Calculate the new maintenance dose
New dose = 600 mg * 0.55 = 330 mg
For linear pharmacokinetics, the dose is adjusted in direct proportion to the change in total clearance to maintain the same steady-state concentration.

Key Concept

Pharmacokinetic dose adjustment in mixed-elimination drugs based on diminished renal clearance.
Question 3738Question →

A 26-year-old female marathon runner is brought to the emergency department by her partner due to sudden-onset shortness of breath, headache, and a noticeable bluish discoloration of her lips and fingertips. She has no significant past medical history and takes no daily prescription medications. Three days ago, she sustained a minor hamstring strain during a training run and has been treating it at home. On physical examination, the patient is anxious and tachypneic. Vital signs include a blood pressure of 110/70 mmHg, a heart rate of 112/min, and a respiratory rate of 22/min. Pulse oximetry on room air reads 85%. She is immediately placed on 100% oxygen via a non-rebreather mask, but her pulse oximetry reading remains unchanged at 85% after 15 minutes. An arterial blood gas (ABG) analysis obtained while on supplemental oxygen reveals:

pH: 7.42
PaCO2: 36 mmHg
PaO2: 240 mmHg
Calculated SaO2: 99%

Which of the following specific elements of the patient's recent medical history is most critical to elicit to establish the underlying diagnosis?

Show answer & explanation

Answer: Liberal application of an over-the-counter topical benzocaine preparation

Answer

Liberal application of an over-the-counter topical benzocaine preparation
The patient's presentation of cyanosis, a pulse oximetry reading fixed at approximately 85% that does not improve with supplemental oxygen, and a highly elevated PaO2 on arterial blood gas analysis is the classic triad for acquired methemoglobinemia. This condition creates a 'saturation gap' where the SpO2 (measured by pulse oximetry) is falsely low, while the PaO2 (dissolved oxygen in the plasma) remains normal or high. Pulse oximeters are unreliable in methemoglobinemia because the oxidized iron (Fe3+) in methemoglobin absorbs light equally at the 660 nm and 940 nm wavelengths, forcing the reading toward 85%. In healthy adults, this condition is almost always acquired via exposure to an oxidizing agent. Topical anesthetics such as benzocaine, commonly used over-the-counter for musculoskeletal injuries, sunburns, or oral pain, are frequent culprits. Discovering the use of this topical agent in her recent medical history is the most critical step to establish the diagnosis and prompt treatment with methylene blue.

Step-by-Step Solution

1
Analyze the patient's vital signs and response to supplemental oxygen.
The patient exhibits cyanosis with a pulse oximetry (SpO2) reading of 85% that completely fails to improve despite the administration of 100% oxygen.
A lack of response to high-flow oxygen strongly suggests a hemoglobinopathy or a significant right-to-left shunt, rather than a standard ventilation/perfusion (V/Q) mismatch.
2
Evaluate the arterial blood gas (ABG) results in the context of the pulse oximetry findings.
The ABG demonstrates a highly elevated PaO2 (240 mmHg), revealing a profound 'saturation gap' between the low SpO2 (85%) and the normal/high dissolved oxygen in the blood.
A saturation gap is the hallmark of dyshemoglobinemias, most notably methemoglobinemia. Methemoglobin absorbs light equally at the two wavelengths used by standard pulse oximeters, driving the reading artificially toward 85% regardless of true oxygen tension.
3
Identify common historical triggers for this condition in a healthy adult.
Acquired methemoglobinemia in adults is typically triggered by exposure to oxidizing agents such as topical anesthetics (benzocaine, prilocaine), dapsone, or nitrites.
Eliciting a history of using a topical benzocaine cream for her recent hamstring strain connects the inciting exposure directly to the pathophysiology of her cyanosis.

Key Concept

Acquired methemoglobinemia classically presents with cyanosis and a 'saturation gap' (a falsely low SpO2 reading near 85% paired with a normal or high PaO2) and is frequently triggered by the use of oxidizing agents such as topical benzocaine.
Estimated Time:1m 30s
Question 3739Question →

A 29-year-old man presents to an outpatient clinic with a 5-day history of fever, severe pharyngitis, profound fatigue, and a nonpruritic maculopapular rash on his trunk and extremities. He has no significant past medical history. Social history is notable for unprotected receptive anal intercourse with a new male partner 16 days ago. His temperature is 38.3°C (100.9°F), blood pressure is 118/76 mmHg, pulse is 102/min, and respirations are 16/min. Physical examination reveals generalized cervical and axillary lymphadenopathy. The physician suspects acute retroviral syndrome and initiates the standard diagnostic algorithm and pre-treatment evaluation.

Arrange the following laboratory tests in the most appropriate chronological sequence for establishing the definitive diagnosis, evaluating the baseline disease state, and preparing for the initiation of antiretroviral therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the 4th-generation combination immunoassay, followed by the antibody differentiation immunoassay, then the HIV-1 NAT to resolve indeterminate acute results, followed by baseline staging with CD4/viral load, and finally pre-treatment resistance and pharmacogenomic screening.
The evaluation of suspected acute HIV infection follows a strict diagnostic algorithm established by the Centers for Disease Control and Prevention (CDC), followed by a standardized pre-treatment baseline assessment. The process begins with the highly sensitive fourth-generation HIV-1/2 antigen/antibody combination immunoassay. If reactive, this must be followed by an HIV-1/HIV-2 antibody differentiation immunoassay. In acute HIV infection, the differentiation assay is typically negative or indeterminate because the p24 antigen (detected by the first test) appears before fully mature antibodies (detected by the second test). To resolve this discordance and confirm acute infection, an HIV-1 nucleic acid amplification test (NAT) is required. Once the diagnosis is definitively established, the physician must order baseline staging laboratories, primarily a CD4+ T-lymphocyte count and a quantitative HIV-1 RNA viral load. Finally, prior to or concurrent with initiating antiretroviral therapy, genotypic resistance testing and HLA-B*5701 allele screening must be performed to ensure the selected regimen is both effective and safely tailored to the patient.

Step-by-Step Solution

1
Perform initial screening for HIV infection.
Fourth-generation HIV-1/2 antigen/antibody combination immunoassay.
This is the most sensitive initial screening test, capable of detecting both HIV antibodies and the p24 antigen, which appears earlier in the course of acute infection.
2
Confirm a positive initial screening test and differentiate the viral type.
HIV-1/HIV-2 antibody differentiation immunoassay.
Required to distinguish between HIV-1 and HIV-2 infections and to confirm the presence of antibodies. In acute HIV, this test is often negative or indeterminate because mature antibodies have not yet fully developed.
3
Resolve indeterminate or negative differentiation assay results in the setting of suspected acute infection.
HIV-1 nucleic acid amplification test (NAT).
Directly detects viral RNA. A positive NAT following a positive 4th-generation screen and a negative/indeterminate differentiation assay definitively diagnoses acute HIV-1 infection.
4
Establish baseline disease stage and immunological status after confirming the diagnosis.
CD4+ T-lymphocyte count and quantitative HIV-1 RNA viral load.
Essential for assessing baseline immune function and the magnitude of viremia, which guides clinical monitoring and establishes a reference point to assess future virologic suppression on therapy.
5
Optimize the initial antiretroviral therapy (ART) regimen for safety and efficacy.
Genotypic antiretroviral drug resistance testing and HLA-B*5701 allele screening.
Identifies transmitted drug resistance mutations and screens for potential abacavir hypersensitivity, ensuring the selected standard ART regimen is both effective and safe for the specific patient.

Key Concept

Standard HIV diagnostic testing algorithm and subsequent baseline pre-treatment evaluation sequence.
Question 3740Question →

A 2828-year-old woman is evaluated in the clinic for a 66-month history of extreme fatigue, abdominal bloating, and frequent, bulky, foul-smelling bowel movements. She has unintentionally lost 4.54.5 kg (1010 lb) during this period. Her medical history is significant for three distinct episodes of acute bacterial sinusitis over the past year. She takes no medications and has no known drug allergies. Vital signs are within normal limits. Physical examination reveals mild conjunctival pallor and a mildly distended abdomen with hyperactive bowel sounds. Initial laboratory testing shows:

Hemoglobin: 10.110.1 g/dL
Mean corpuscular volume: 7474 fL
Ferritin: 88 ng/mL (normal: 1515-200200 ng/mL)
Tissue transglutaminase (tTG) IgA antibody: Negative
Total serum IgA: 44 mg/dL (normal: 7070-400400 mg/dL)

Which of the following is the most appropriate next step in laboratory evaluation?

Show answer & explanation

Answer: Serum deamidated gliadin peptide (DGP) IgG and tissue transglutaminase (tTG) IgG antibodies

Answer

Serum deamidated gliadin peptide (DGP) IgG and tissue transglutaminase (tTG) IgG antibodies
The correct answer is serum deamidated gliadin peptide (DGP) IgG and tissue transglutaminase (tTG) IgG antibodies. This patient presents with classic signs of malabsorption (steatorrhea, weight loss) and iron deficiency anemia, which are highly suggestive of celiac disease. Her initial screening test, tTG IgA, is negative. However, the laboratory results also show concurrent selective IgA deficiency (total IgA <5< 5 mg/dL). Selective IgA deficiency is up to 1010 to 1515 times more common in patients with celiac disease than in the general population, and it classically presents with recurrent sinopulmonary infections, as seen in this patient's history. Because she lacks sufficient IgA, any IgA-based serology will be falsely negative. The most appropriate next step in laboratory evaluation is to order IgG-based celiac serologies, such as DGP IgG and tTG IgG, to accurately assess for the disease before proceeding to confirmatory endoscopy.

Step-by-Step Solution

1
Analyze the clinical presentation and initial laboratory findings.
The patient has chronic malabsorptive diarrhea, weight loss, and iron deficiency anemia, which is highly suspicious for celiac disease.
Establishing the pre-test probability is essential for interpreting the subsequent serologic tests.
2
Interpret the specific serologic panel provided in the stem.
The tissue transglutaminase (tTG) IgA is negative, but the total serum IgA is profoundly low (44 mg/dL), indicating selective IgA deficiency.
Selective IgA deficiency is more common in patients with celiac disease. Its presence invalidates the negative predictive value of any IgA-based screening test.
3
Determine the next branch of the diagnostic algorithm.
Order IgG-based celiac serologies (DGP IgG and tTG IgG).
When a patient lacks sufficient endogenous IgA, IgG-based antibodies must be measured to accurately screen for celiac disease prior to considering endoscopy.

Key Concept

In patients suspected of having celiac disease who have concurrent selective IgA deficiency, standard IgA-based serologic tests (like tTG IgA) will be falsely negative; therefore, IgG-based serologies (such as DGP IgG and tTG IgG) must be ordered.
Estimated Time:1m 15s
PreviousPage 187 / 237Next